New research may benefit infants who are born pre-term and may eventually become blind due to the early birth.
A rather inexpensive drug has been found to treat blindness better than current, recommended therapies.
Of all babies treated with Avastin, a drug used to prevent the recurrence of blindness, less than 5 percent noticed the condition to continue.
However, the condition was found to continually affect infants in as many as 25 percent of the cases where laser treatment was used.
The new method of treatment involves an injection directly into the eye, and it costs less than $50 for both eyes.
Experts explain this may be an extremely beneficial treatment, as it has shown long-term effects, and at just around $40 to treat both eyes, it really is hard to argue against the treatment.
The drug works by not allowing abnormal blood vessel growth in the eyes, which is the primary cause of the condition.
Researchers believe the treatment will be effective for the long-term, and will save babies from potential blindness.
Experts explain that while many benefits were noticed, the study size, less than 150 infants, raises some concern.
Additional studies are to be conducted about how beneficial this treatment actually is.